Day: September 13, 2022

Pavement Announce 2023 Australian Tour

US indie-rock legends Pavement have announced their return to Australia. The veteran group will tour the country in early 2023 as part of their long-delayed reunion celebrations. Kicking off in February 2022, the group will perform six theatre headline dates in Perth, Adelaide, Brisbane, Thirroul, Sydney, and Melbourne. Additionally, the group will also appear at both […]

Altair to Acquire RapidMiner, Continuing Expansion of Broad Data Analytics Portfolio

Key technology extends reach and scale of data analytics suite TROY, Mich., Sept. 14, 2022 /PRNewswire/ — Altair (Nasdaq: ALTR), a global leader in computational science and artificial intelligence (AI), signed a definitive agreement to acquire RapidMiner, a leader in advanced data analytics and machine learning (ML) software. RapidMiner’s low-code platform is used by more than one million […]

Quark Expeditions Introduces the Most Flexible Booking Policy in the Industry–The Quark Protection Promise

SEATTLE, Sept. 14, 2022 /PRNewswire/ — Quark Expeditions, the global Leader in Polar Adventures, has introduced The Quark Protection Promise, the most flexible and consumer-friendly booking policy in the expedition industry—and it’s permanent! “The pandemic dramatically impacted the travel industry, ultimately challenging companies to enrich their booking terms with greater flexibility,” said Wendy Batchelor, Vice-President […]

Hilco Global Sells Heavy Plate Mill in Germany to an Asian Steel Producer

NORTHBROOK, Ill., Sept. 14, 2022 /PRNewswire/ — Amsterdam-based Hilco Industrial Acquisitions, B.V., an operating company of U.S.-based Hilco Global, announced today the sale of all assets at ThyssenKrupp Heavy Plate Rolling Mill facility located in Duisburg-Hüttenheim, Germany to an Asian Steel Producer.  The sale comes only six months after Hilco Industrial Acquisitions, B.V. first acquired […]

Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence

Debiopharm Innovation Fund strategically invests in Whitelab Genomics’ mission to make genomic medicine development faster and leaner for more efficient access to cancer patients in the future LAUSANNE, Switzerland, Sept. 14, 2022 /PRNewswire/ — Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm (, announced today their investment in Whitelab Genomics alongside […]

Back To Top